By: ICN Bureau
Last updated : October 11, 2024 10:34 am
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Privi Speciality Chemicals Limited has received "Certificate of API (Active Pharmaceuticals lngredient) Product Listing" and "Certificate of Registration" for its camphor product from U.S. Food and Drug Administration (USFDA).
Having received the said registration, the company can now expand its business horizon into the area of pharmaceutical applications in the USA.
The company has already received license for manufacture, sale, and distribution of camphor (Form 25) from Food and Drugs Administration, Maharashtra state which enables it to sell camphor to the Indian pharmaceutical companies.